18F-fluorobenzyl triphenyl phosphonium: A noninvasive sensor of brown adipose tissue thermogenesis

Journal of Nuclear Medicine

Volumn 52, Issue 5, 2011, Pages 808-814

  Madar, Igal ^a   Isoda, Takuro ^a   Finley, Paige ^a   Angle, James ^a   Wahl, Richard ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

18F FBnTP; 18F FDG; Brown adipose tissue; PET; Thermogenesis

Indexed keywords

FLUOROBENZYLTRIPHENYLPHOSPHONIUM C 14; FLUOROBENZYLTRIPHENYLPHOSPHONIUM F 18; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROPRANOLOL; RADIOISOTOPE; UNCLASSIFIED DRUG; 18F FLUOROBENZYL TRIPHENYL PHOSPHONIUM; 18F-FLUOROBENZYL TRIPHENYL PHOSPHONIUM; CARBON; NORADRENALIN; ORGANOPHOSPHORUS COMPOUND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSENSOR; BROWN ADIPOSE TISSUE; COLD EXPOSURE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; HEART; ISOTOPE LABELING; KIDNEY PARENCHYMA; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; THERMOGENESIS; ANIMAL; COLD; CYTOLOGY; DRUG EFFECT; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOCYTES, BROWN; ANIMALS; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; COLD TEMPERATURE; FLUORODEOXYGLUCOSE F18; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NOREPINEPHRINE; ORGANOPHOSPHORUS COMPOUNDS; PROPRANOLOL; RATS; TECHNETIUM TC 99M SESTAMIBI; THERMOGENESIS;

EID: 79955786485     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.084657     Document Type: Article

References (40)

1. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med. 2006;12:75-80. (Pubitemid 43050080)
2. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov. 2010;9:107-115.
3. Bray GA. Drug insight: appetite suppressants. Nat Clin Pract Gastroenterol Hepatol. 2005;2:89-95. (Pubitemid 40790155)
4. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006;29:277-302.
5. Tseng YH, Cypess AM, Kahn CR. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov. 2010;9:465-482.
6. Foster DO, Frydman ML. Tissue distribution of cold-induced thermogenesis in conscious warm or cold-acclimated rats reevaluated from changes in tissue blood flow: the dominant role of brown adipose tissue in the replacement of shivering by nonshivering thermogenesis. Can J Physiol Pharmacol. 1979;57:257-270. (Pubitemid 9155091)
7. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277-359. (Pubitemid 38054374)
8. Cohade C, Mourtzikos KA, Wahl RL. "USA-Fat": prevalence is related to ambient outdoor temperature - evaluation with 18F-FDG PET/CT. J Nucl Med. 2003;44:1267-1270. (Pubitemid 39655187)
9. 18F-FDG PET CT. J Nucl Med. 2003;44:170-176.
10. 18FFDG uptake in brown fat can be reduced pharmacologically. J Nucl Med. 2004;45:1189-1193.
11. 99mTc methoxyisobutylisonitrile on SPECT/CT. J Nucl Med. 2008;49:752-756.
12. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518-1525.
13. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509-1517.
14. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500-1508.
15. Saito M, Okamatsu-Ogura Y, Matsushita M, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009;58:1526-1531.
16. Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:E444-E452. (Pubitemid 47205086)
17. Rousseau C, Bourbouloux E, Campion L. at el. Brown fat in breast cancer patients: analysis of serial 18F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging. 2006;33:785-791. (Pubitemid 43979686)
18. Nicholls DG, Locke RM. Thermogenic mechanisms in brown fat. Physiol Rev. 1984;64:1-64. (Pubitemid 14139945)
19. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta. 2001;1504:82-106. (Pubitemid 32179660)
20. Matthias A, Ohlson KB, Fredriksson JM, Jacobsson A, Nedergaard J, Cannon B. Thermogenic responses in brown fat cells are fully UCP1-dependent: UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty acid-induced thermogenesis. J Biol Chem. 2000;275:25073-25081.
21. López-Soriano FJ, Fernández-López JA, Mampel T, Villarroya F, Iglesias R, Alemany M. Amino acid and glucose uptake by rat brown adipose tissue: effect of cold-exposure and acclimation. Biochem J. 1988;252:843-849.
22. 18F)-fluorobenzyl triarylphosphonium ions. J Labelled Comp Radiopharm. 2004;47:469-476.
23. 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med. 2006;47:1359-1366.
24. 18F-fluorobenzyl triphenylphosphonium cation. Eur J Nucl Med Mol Imaging. 2007;34:2057-2065.
25. Murphy MP, Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev. 2000;41:235-250. (Pubitemid 30122962)
26. Nicholls DG. The effective proton conductance of the inner membrane of mitochondria from brown adipose tissue: dependency on proton electrochemical potential gradient. Eur J Biochem. 1977;77:349-356. (Pubitemid 8142831)
27. Bouillaud F, Ricquier D, Mory G, Thibault J. Increased level of mRNA for the uncoupling protein in brown adipose tissue of rats during thermogenesis induced by cold exposure or norepinephrine infusion. J Biol Chem.1984;259:11583- 11511.
28. Beattie JH, Black DJ, Wood AM, Trayhurn P. Cold-induced expression of the metallothionein-1 gene in brown adipose-tissue of rats. Am J Physiol.1996;270:R971-R977.
29. Nicholls DG. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med. 2004;4:149-177. (Pubitemid 38425912)
30. 99mTc-tetrofosmin. J Nucl Med. 2007;48:1021-1030.
31. Cypess AM, Kahn CR. Brown fat as a therapy for obesity and diabetes. Curr Opin Endocrinol Diabetes Obes. 2010;17:143-149.
32. Kontani Y, Wang Y, Kimura K. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell. 2005;4:147-155. (Pubitemid 41602748)
33. Argyropoulos G, Harper ME. Uncoupling proteins and thermoregulation. J Appl Physiol. 2002;92:2187-2198.
34. Frühbeck G, Becerril S, Sáinz N, Garrastachu P, García Velloso MJ. BAT: a new target for human obesity? Trends Pharmacol Sci. 2009;30:387-396.
35. Ghorbani M, Claus TH, Himms-Hagen J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem Pharmacol. 1997;54:121-131. (Pubitemid 27353229)
36. Guerra C, Koza RA, Yamashita H, et al. Emergence of brown adipocytes in white fat in mice is under genetic control: effects on body weight and adiposity. J Clin Invest. 1998;102:412-420. (Pubitemid 28335201)
37. Lowell BB, Susulic V, Hamann A, et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 1993;366:740-742. (Pubitemid 24038513)
38. Melnikova I,Wages D. Antiobesity therapies. Nat Rev Drug Discov. 2006;5:369-370.
39. Rothwell NJ, Stock MJ. Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour. Clin Sci (Lond). 1983;64:19-23. (Pubitemid 13207247)
40. Wangsness M. Pharmacological treatment of obesity: past, present, and future. Minn Med. 2000;83:21-26.